20. She revealed that a part of the reason why she started making her food from scratch was due to a flare-up of her eczema and eventual lupus diagnosis when she was pregnant. Chris Saucedo/Getty ...

Lupus is a complex chronic condition that can affect multiple systems of the body. Management typically involves medications that modify the immune system, but natural treatments may also help ...

The 1.5 million Americans estimated to have the autoimmune disease lupus already have plenty to manage—what with the pain, fatigue, hair loss, and heart problems the condition can cause.

Identifying and addressing disparities among people living with lupus ensures communities with the highest burden of disease, like racial and ethnic minorities, receive equitable opportunities for ...

Living with lupus can affect your social, emotional, and financial wellbeing. But there are things you can do to cope with lupus and get the support you need. When you’re living with lupus, managing ...

There are several lupus treatment options. However, there is no “best" treatment for lupus because each person living with the condition will have their own needs and goals for managing it. Lupus ...

Pooled data analysis from 22 studies. † Lupus in minorities: nature versus nurture [Unpublished Observ., May 2008]. Lupus occurs only in young women Lupus may occur at any age and in both ...

Experts have called for greater awareness of lupus to promote better access to healthcare for those living with the condition. The call was made on Saturday at a lupus awareness programme ...

If you have lupus, you're likely to have skin issues at some point, but treatment can bring relief. Your doctor will likely prescribe a topical medication, such as a steroid cream or gel ...

"Lupus was the perfect disease for us!" showrunner David Shore says with a laugh ahead of the 20th anniversary. The doctor is back in. Well, sort of. And unlike Hugh Laurie's brilliant but ...

Not content with getting the first lupus drug to market in the form of the blockbuster Benlysta more than a decade ago, GSK is handing over $300 million in upfront cash for a clinical-stage T-cell ...